Sophia Dunlap

Sophia Dunlap

Auto-generated profile, based on publicly available information

Sophia Dunlap

Department of Pathology, Division of Molecular and Cellular Pathology, University of Alabama at Birmingham, Birmingham, AL, USA

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
CHCaitlin A. Harvey
Caitlin A. Harvey
SDSophia Dunlap
Sophia Dunlap
MMMostafa Mohamed
Mostafa Mohamed
EKEshika Kudaravalli
Eshika Kudaravalli
AEAmr Elkholy
Amr Elkholy
EAEun-Young Erin Ahn
Eun-Young Erin Ahn
Glioblastoma (GBM) exhibits extensive loss of circular RNAs (circRNAs), yet the mechanisms driving this depletion and its functional consequences remain unclear. Here, we identify the splicing co-factor SON as a previously unrecognized suppressor of circRNA biogenesis in GBM. CircRNA sequencing revealed widespread increases in circRNA abundance following SON knockdown. Conversely, elevated SON expression in GBM, with further increases in radiation-resistant models, was associated with widespread circRNA loss, including reduced expression of circUSP1 and circSUCO. SON knockdown increased circRNA abundance and attenuated activation of the dsRNA-responsive kinase PKR and downstream NFκB signaling, whereas radiation-resistant GBM cells exhibited enhanced PKR/NFκB activation that was attenuated by SON depletion. Importantly, overexpression of the SON-suppressed circRNAs circUSP1 and circSUCO reduced PKR activation and selectively decreased clonogenic survival following irradiation in radiation-resistant GBM cells, with little effect on parental cells. Together, these findings identify a previously unrecognized SON/circRNA/PKR regulatory pathway linking RNA processing to acquired radiation resistance in GBM and highlight specific PKR-inhibitory circRNAs as potential therapeutic tools for resensitizing radiation-resistant GBM to radiotherapy.

15 July 2026 in bioRxiv
Verified
Preprint
Open access
MAMonima Anam
Monima Anam
TSTaylor L Schanel
Taylor L Schanel
SDSophia Dunlap
Sophia Dunlap
MMMostafa Mohamed
Mostafa Mohamed
EAEun-Young Erin Ahn
Eun-Young Erin Ahn
ZSZhangli Su
Zhangli Su
Summary: Glioblastoma (GBM) is a highly lethal brain cancer with limited therapeutic durability, where the majority of patients develop recurrent or persistent disease after standard chemoradiotherapy. Meanwhile, tRNA-derived fragments (tRFs) have become increasingly relevant to cancer biology; however, their clinical relevance in GBM remains undefined. Here, we report that a specific family of tRFs, 5’-tRNA halves (tiR5s) dominates the small RNA landscape of GBM patient tumors and associates with worse overall survival, post-therapeutic disease persistence, and pro-invasive proteogenomic pathways across two independent GBM patient cohorts. This association between elevated tiR5 levels and therapeutic resistance re-emerges in radiation-resistant GBM xenograft models. Our findings reveal that tiR5s are an underappreciated molecular feature of highly aggressive GBM tumors, supporting further investigation into their biological roles and prognostic utility in GBM. Highlights: tiR5s are the predominant tRF family in primary GBM patient tumors Elevated tiR5 expression distinguishes primary GBM tumors that develop persistent disease after first-line therapy Radiation-resistant GBM PDX models show elevated tiR5 expression Elevated tiR5 expression associates with poor overall patient survival and pro-invasive molecular programs in GBM patient tumors Graphical

9 October 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
SDSophia K. Dunlap
Sophia K. Dunlap
CHCaitlin A. Harvey
Caitlin A. Harvey
AEAmr Elkholy
Amr Elkholy
LGLeah Gehrs
Leah Gehrs
MMMostafa Mohamed
Mostafa Mohamed
EAEun-Young Erin Ahn
Eun-Young Erin Ahn
Glioblastoma (GBM) is characterized by near-universal recurrence and resistance to therapy. Although tumor-intrinsic mechanisms of radiation resistance have been extensively studied, how the extracellular matrix influences signaling in radiation-resistant GBM remains poorly understood. Here, we investigated discoidin domain receptor 1 (DDR1), a collagen-activated receptor tyrosine kinase, using matched radiation-sensitive parental and radiation-resistant patient-derived GBM models generated through serial in vivo irradiation. Within a three-dimensional collagen I matrix, radiation-resistant GBM cells exhibited distinct temporal patterns of Ki-67 positivity and ERK1/2 phosphorylation compared with parental cells. Despite increased DDR1 expression, radiation-resistant cells exhibited markedly reduced DDR1 phosphorylation and enhanced ectodomain shedding, characterized by accumulation of the membrane-associated C-terminal fragment and release of the N-terminal fragment. DDR1 depletion reduced ERK1/2 phosphorylation, supporting its contribution to ERK1/2 signaling under these conditions. ADAMTS1 was markedly upregulated in radiation-resistant cells, and its knockdown reduced DDR1 ectodomain shedding while increasing full-length DDR1 abundance, ERK1/2 and RB phosphorylation, cyclin D1 expression, and Ki-67 positivity. Together, these findings reveal a distinct DDR1 regulatory state in acquired radiation-resistant GBM, characterized by enhanced ADAMTS1-associated ectodomain shedding, reduced receptor phosphorylation, and attenuated proliferative signaling within a three-dimensional collagen I matrix.